Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Navigating Life Sciences Strategic Planning in Eastvale, CA

Jun 18, 2025

Understanding the Unique Landscape of Eastvale, CA

Eastvale, CA, a city that has seen remarkable growth and development, presents a unique landscape for businesses operating in the life sciences sector. Its strategic location in Southern California offers proximity to major urban centers and a thriving community. For life sciences companies, understanding this dynamic environment is crucial for effective strategic planning.

The life sciences sector in Eastvale benefits from a supportive local government and access to a skilled workforce. Companies looking to establish or expand their presence here must consider these factors as they develop their strategic plans. The location provides a blend of suburban tranquility and urban accessibility, making it an attractive option for businesses and employees alike.

Moreover, Eastvale's commitment to innovation and technology is evident in its infrastructure and community initiatives. This focus creates a fertile ground for life sciences companies aiming to leverage cutting-edge technologies and research advancements.

life sciences Eastvale

Key Considerations for Strategic Planning

When navigating strategic planning in Eastvale, life sciences companies should prioritize several key factors. First and foremost, understanding the regulatory environment is essential. California's regulations can be stringent, but they also ensure high standards that can enhance a company's reputation.

Another important consideration is the need for collaboration. Eastvale's proximity to leading research institutions and universities provides ample opportunities for partnerships. Engaging with academic institutions can facilitate access to research breakthroughs and emerging talent.

Additionally, companies should be aware of the competitive landscape. With numerous life sciences firms in the region, distinguishing your company through innovative products or services can be vital to success.

strategic planning

Steps to Develop a Robust Strategic Plan

Developing a robust strategic plan involves a series of steps tailored to the unique opportunities and challenges of Eastvale. Here’s a suggested approach:

  1. Conduct a Thorough Market Analysis: Understand the local market dynamics, including customer needs, competitor activities, and potential collaborators.
  2. Identify Regulatory Requirements: Stay informed about relevant regulations and compliance standards to ensure smooth operations.
  3. Leverage Local Resources: Utilize local talent pools and research institutions to bolster innovation and growth.
  4. Build Strategic Partnerships: Collaborate with universities, research centers, and other businesses to expand your reach and capabilities.
  5. Focus on Sustainability: Incorporate sustainable practices into your operations to align with increasing environmental concerns.

The Role of Innovation in Life Sciences

Innovation is at the heart of life sciences, driving advancements that improve health outcomes and patient care. In Eastvale, companies have access to an ecosystem that supports innovation through technology parks, incubators, and funding opportunities. Embracing innovation requires not only investment in R&D but also cultivating a culture that encourages creativity and risk-taking.

Furthermore, staying abreast of emerging trends such as personalized medicine, biotechnology advances, and digital health solutions can position your company as a leader in the industry. Being proactive in these areas allows businesses to anticipate shifts in market demand and adapt accordingly.

innovation health

Conclusion: Seizing Opportunities in Eastvale

The life sciences sector in Eastvale is ripe with opportunities for growth and development. By understanding the local landscape, leveraging available resources, and fostering innovation, companies can create strategic plans that not only meet current needs but also anticipate future challenges. Navigating this vibrant market with a well-considered strategy can lead to sustained success and impactful contributions to the field of life sciences.